1Greene FL,Page DL,Fleming ID,et al.AJCC cancer staging handbook from the AJCC cancer staging manual,6th edn[M].NewYork:Springer,2002.
2Min HQ,Hong MH,Ma J,et al.Anewstaging system for nasopharyngeal carci-noma in China[J].Int J Radiat Oncol Biol Phys,1994,30(5):1037-42.
3马骏,闵华庆,洪明晃,等.鼻咽癌′92分期的临床验证[J].癌症,1999,18Suppl:44-45.
4Hong MH,Mai HQ,Min HQ,etal.Acomparison of the Chinese1992and Fifth-edition International Union Against Cancer Staging Systems for staging nasopharyn-geal carcinoma[J].Cancer,2000,89:242-247.
5谢传淼,梁碧玲,林浩皋,等.MRI对鼻咽癌T、N分期的影响[J].中华肿瘤杂志,2002,24:181-184.
6张瑜,潘建基,陈旭霞,等.CT与MRI对鼻咽癌T分期影响的比较[J].福建医科大学学报,2004,38:101-103.
7孙颖,毛燕萍,马骏,等.MRI在鼻咽癌分期中的作用[J].癌症,2007,26:158-163.
8魏宝清.论我国鼻咽癌分期亟须解决的问题[J].肿瘤学杂志,2006,12:259-261.
9宗井凤,马骏,唐玲珑,等.鼻咽癌综合治疗策略研究—749例疗效分析[J].中国肿瘤,2005,14:538-542.
10高黎,易俊林,黄晓东,等.鼻咽癌根治性放疗10年经验总结[J].中华放射肿瘤学杂志,2006,15:249-256.
11宗井凤,马骏,唐玲珑,等.鼻咽癌临床分期因素的意义探讨[J].国际肿瘤学杂志,2006,33:71-75.
12中国鼻咽癌临床分期工作委员会.鼻咽癌′92分期修订工作报告[J].中华放射肿瘤学杂志,2008,18(1):2-6.
13King AD,Teo P,Lam WW,et al.Paranasopharyngeal space involvement in na-sopharyngeal cancer:detection by CTand MRI[J].Clin Oncol,2000,12(6):397-402.
14谢传淼,梁碧玲,林浩皋,等.MRI对鼻咽癌T、N分期的影响[J].中华肿瘤杂志,2002,24:181-184.
15Ng SH,Wan YL,Ko SF,etal.MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy[J].J Magn Reson Imaging,1998,8:327-336.
16Chong VF,Fan YF.Skull base erosion in nasopharyngeal carcinoma:detection by CTand MRI[J].Clin Radiol,1996,51:625-31.
17Casselman JW.The value of MRI in the diagnosis and staging of nasopharynx tumors[J].J Belge Radiol,1994,77:67-71.
18孙颖,马骏,黄莹,等.鼻咽癌的CT与MRI对比研究[J].中国肿瘤临床,2005,32(14):788-791.
19韩晶,沈文荣,何侠,等.鼻咽癌的CT与MRI对比分析[J].肿瘤学杂志,2006,12:279-281.
20苏勇,赵充,谢传淼,等.CTMRI和PET-CT对鼻咽癌局部肿瘤检测差异的初步研究[J].中国肿瘤临床,2007,34:245-250.
21胡伟汉,张国义,刘立志,等.PET-CT与MRI诊断鼻咽癌淋巴结转移的对比研究[J].癌症,2005,24:855-860.
22魏宝清.对比88例鼻咽癌的MRI与CT及研究茎突后间隙受累的组成[J].中华放射肿瘤学杂志,1996,5:77-80.
23高剑铭,曾益新,崔念基,等.915例单纯根治性放疗鼻咽癌分期系统比较及建议(一).癌症,2005,24:1165-72.
24毛燕萍,洪明滉,孙颖等.鼻咽癌临床分期的研究-对′92分期改进的建议[J].癌症,2007,26:1099-1106.
25Harnsberger HR,Osborn AG,Ross JS,etal.Diagnostic and surgical imaginga-natomy:brain,head&neck,spine.Salt Lake:Amirsys,2006:198-199.
26Williams LS,Mancuso AA,Mendenhall WM.Perineural spread of cutaneous squamous and basal cell carcinoma:CTand MR detection and its impact on pa-tient management and prognosis[J].Int J Radiat Oncol Biol Phys,2001,49(4):1061-1069.
27Sham JST,Choy MB,Wei WI,et al.Nasopharyngeal carcinoma:orderly neck node spread[J].Int J Radiat Oncol Biol Phys,1990,19:929-933.
28King AD,Ahuja AT,Leung SF,et al.Neck node metastases from nasopharyngeal carcinoma:MR imaging of patterns of disease[J].Head Neck,2000,22:275-281.
29孙颖,马骏,卢泰祥,等.512例鼻咽癌颈淋巴结转移规律的研究[J].癌症,2004,232Suppl,11:1523-27.
30Ma J,Liu LZ,Tang LL,et al.Retropharyngeal lymph node metastasis in naso-pharyngeal carcinoma:prognostic value and staging categories[J].Clin Cancer Res,2007,13:1445-52.
31Heng DMK,Wee J,Fong KW,et al.Prognostic factors in677patients in singa-pore with nondisseminated nasopharyngeal carcinoma[J].Cancer,1999,86:1912-20.
32Lee AW,Foo W,Law SC,et al.Staging of nasopharyngeal carcinoma:from Ho’s to the newUICC system[J].Int J Cancer,1999,84:179-187.
33Mao YP,Liang SB,Liu LZ,et al.The Nstaging system in nasopharyngeal car-cinoma with Radiation Therapy Oncology Group guidelines for lymph node levels based on magnetic resonance imaging[J].Clin Cancer Res,2008,14:7947-7903.
34马骏,毛燕萍.鼻咽癌的TNM临床分期研究进展[J].中国癌症杂志,2008,18(9):648-654.
35Mao YP,Liang SB,Liu LZ,et al.The Nstaging system in nasopharyngeal car-cinoma with Radiation Therapy Oncology Group guidelines for lymph node levels based on magnetic resonance imaging[J].Clin Cancer Res,2008;14(22):7947-53.
36van den Brekel MW,Stel HV,Castelijns JA,et al.Cervical lymph node metas-tasis:assessment of radiologic criteria[J].Radiology,1990,177:379-384.
37Gregoire V,Eisbruch A,Hamoir M,et al.Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck[J].Radiother On-col,2006,79:15-20.
38Gregoire V,Levendag P,Ang KK,et al.CT-based delineation of lymph node levels and related CTVs in the node-negative neck:DAHANCA,EORTC,GORTEC,NCIC,RTOG consensus guidelines[J].Radiother Oncol,2003,69:227-236. |